New Multimetrix GmbH Diagnostics On the Market
Multimetrix GmbH was founded in Regensburg’s Bio Park in 2002 and has been developing multiplex-test panels for clinical diagnostics on the basis of fluorescent micro-spheres (e.g. infectionserology and auto-immune diagnostics). The first marketable products were successfully presented at the MEDICA – Medical Product Trade Show in November 2002 in Düsseldorf. The new multiplex test systems allow for the simultaneous diagnosis of several specific antibodies in the blood serums of patients, e.g. after infection from Lime disease (Tiboplex™), from tick bites, or infection from the Epstein-Barr virus.
The quantitative analysis of the antibodies allows for an exact diagnosis of the status and stage of the infection and therefore makes a more targeted treatment possible. Another test kit, Lymphoplex™, measures various cytokines (= chemical messengers, e.g. interferone in the immune system) in smallest concentrations. These Lymphoplex™-tests are used primarily for biomedical research. The PROGEN Biotechnik GmbH, founded in 1983 on the Heidelberg Campus, markets the Multimetrix products that are produced in Regensburg. Majority shareholder of PROGEN is Pharma GmbH in Ulm, which is a holding company in the MERCKLE/ratiopharm group. Multiplex works closely together with Luminex Corp., a NASDAQ listed Biotech company based in Austin, Texas (USA). This partnership makes the international orientation of the firms within the BioPark Regensburg once more apparent.
For more information see: